Skip to content
Screener

Pediatrix Medical Group MD Q4 2025 Annual earnings

Reported February 19, 2026 · Before market open

Revenue$493.8MBeat by $7.5M
EPS$0.50Miss by $0.03
Revenue estimate$486.2M
EPS estimate$0.53

Next report

Nov 2, 2026 (In 2 weeks)
Revenue estimate$498.2M
EPS estimate$0.65

Financials

Q4 2025

Income statement

See full
Revenue$493.8M-1.7%
Operating income$48.8M—
Net income$33.7M—
EPS (diluted)$0.40—

Balance sheet

See full
Cash & equivalents$375.2M+63.2%
Total debt$638.0M-4.4%
Total equity$865.9M+13.2%
Total assets$2.2B+4.4%

Cash flow

See full
Operating cash flow$114.1M-14.2%
CapEx$5.3M+53.7%
Free cash flow$108.8M-16.0%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$1.84B+63.0%
Enterprise value$2.1B+34.2%
P/E11.1×—
P/S1×+0.4×

Profitability

See full
Operating margin10.9%—
Net margin8.6%—
FCF margin13.2%+4.0pp

Returns & leverage

See full
Return on equity20.3%—
Debt / equity0.7×-0.1×
Current ratio1.7×+0.2×

Segments

By product

See full
Health Care Patient Service$421.6M-2.0%
Hospitals Contracts$70.0M-2.2%

FAQ

When did Pediatrix Medical Group report Q4 2025 earnings?
Pediatrix Medical Group (MD) reported Q4 2025 earnings on February 19, 2026 before market open.
What were Pediatrix Medical Group's Q4 2025 revenue and EPS?
Pediatrix Medical Group reported revenue of $493.8M and eps of $0.50 for Q4 2025.
Did Pediatrix Medical Group beat estimates in Q4 2025?
Revenue beat the consensus estimate of $486.2M by $7.5M. EPS missed the consensus estimate of $0.53 by $0.03.
How did Pediatrix Medical Group's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 1.7% from $502.4M a year earlier and eps declined 2.0% from $0.51.
Where can I find Pediatrix Medical Group's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-058063) and the 10-K periodic report (0001193125-26-058074) directly on SEC EDGAR. The filing index links above go to sec.gov.